Michael Zinda

Insider Reports History

Location
St Laurent, Quebec, Canada
Signature
/s/ Steve Forte, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Zinda:

Company Role Class Num Shares Value Price $ Report Date Ownership
Repare Therapeutics Inc. EVP, CHIEF SCIENTIFIC OFFICER Common Shares 80,297 $91,539 $1.14 12 Mar 2025 Direct
Repare Therapeutics Inc. EVP, CHIEF SCIENTIFIC OFFICER Employee Stock Option (right to buy) 85,000 04 Mar 2025 Direct

Insider Reports Filed by Michael Zinda

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RPTX Repare Therapeutics Inc. 12 Mar 2025 1 -$6,397 4 EVP, CHIEF SCIENTIFIC OFFICER 14 Mar 2025, 16:30
RPTX Repare Therapeutics Inc. 04 Mar 2025 3 $0 4 EVP, CHIEF SCIENTIFIC OFFICER 06 Mar 2025, 17:00
RPTX Repare Therapeutics Inc. 28 Mar 2024 2 -$3,999 4 EVP, CHIEF SCIENTIFIC OFFICER 01 Apr 2024, 21:28
RPTX Repare Therapeutics Inc. 25 Mar 2024 3 -$6,304 4 EVP, CHIEF SCIENTIFIC OFFICER 27 Mar 2024, 18:57
RPTX Repare Therapeutics Inc. 01 Mar 2024 2 $0 4 EVP, CHIEF SCIENTIFIC OFFICER 04 Mar 2024, 21:06
RPTX Repare Therapeutics Inc. 07 Jun 2023 2 -$42,555 4 EVP, Chief Scientific Officer 09 Jun 2023, 16:25
RPTX Repare Therapeutics Inc. 06 Jun 2023 1 -$14,448 4 EVP, Chief Scientific Officer 07 Jun 2023, 16:55
RPTX Repare Therapeutics Inc. 30 Jan 2023 2 $0 4 EVP, Chief Scientific Officer 01 Feb 2023, 20:46
RPTX Repare Therapeutics Inc. 15 Mar 2022 1 -$6,023 4 EVP, Chief Science Officer 16 Mar 2022, 16:04
RPTX Repare Therapeutics Inc. 18 Jan 2022 1 $0 4 EVP, Chief Science Officer 20 Jan 2022, 15:42
RPTX Repare Therapeutics Inc. 23 Nov 2021 8 +$91,948 4 EVP, Chief Science Officer 06 Dec 2021, 15:47
RPTX Repare Therapeutics Inc. 15 Nov 2021 2 -$546,613 4 EVP, Chief Science Officer 17 Nov 2021, 18:46
RPTX Repare Therapeutics Inc. 16 Aug 2021 2 -$509,886 4 EVP, Chief Science Officer 20 Aug 2021, 16:24
RPTX Repare Therapeutics Inc. 17 May 2021 3 -$490,710 4 EVP, Chief Science Officer 18 May 2021, 17:53